TrialJAMA neurology2015

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

Richard A Nash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.